About Limflow
Limflow is a company based in Paris (France) founded in 2012 was acquired by Inari Medical in November 2023. Limflow has raised $97.45 million across 4 funding rounds from investors including Inari Medical, Bpifrance and Longitude Capital. Limflow offers products and services including LimFlow Procedure. Limflow operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Paris, France
- SectorsHealthcare
- Email••••••••
- Website limflow.com
- Social LinkedIn X
- Acquired by Inari Medical (Nov 2023)
- Legal Name Limflow
- Total Equity Funding$97.45M (USD)
in 4 rounds
- Latest Funding Round$40M (USD), Series D
Apr 2022
- InvestorsInari Medical
& 4 more
- Acquired byInari Medical
(Nov 2023)
Products & Services of Limflow
Limflow offers a comprehensive portfolio of products and services, including LimFlow Procedure.
Procedure designed for patients with severe conditions lacking other options.
Funding Insights of Limflow
Limflow has successfully raised a total of $97.45M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $97.45M
- Total Rounds 4
- Last Round Series D — $40M
- Investors Count 4
All 4 funding rounds of Limflow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | $40M | Series D | – | Longitude Capital, Soleus Capital | |
| Apr 2018 | $33.5M | Series C | – | Sofinnova Partners, Bpifrance | – |
| Oct 2016 | $23.95M | Series B | – | – | – |
| Sep 2014 | – | Series A | – | – | – |
5 investors in total: 5 institutional.
Investors in Limflow
Limflow has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Inari Medical, Bpifrance and Longitude Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on life science sector | – | longitudecapital.com | Menlo Park, United States | |
Sofinnova Partners is focused on life sciences and healthcare investments. | – | sofinnovapartners.com | Paris, France | |
- | – | soleuscapital.com | - | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France | |
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | inarimedical.com | Irvine, United States |
Investor details for Limflow
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Limflow
13 people are tracked at Limflow (6 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Kristi McCaffrey | Director Clinical Affairs | Leadership |
Rowan Hettel | Director, R&d Engineering | Leadership |
Sophie Humbert | COO | Leadership |
Dan Rose | CEO | Leadership |
Stephane Caporusso | Head Of Manufacturing And Supply Chain | Leadership |
Christopher Arbeiter-Grimus | Director EMEA Sales And Market Development Limflow | Leadership |
Matt Gosselin | Area Manager | Team |
Garrett Offerman | Sr. Principal Engineer | Team |
Vincent Cabane | Clinical Affairs | Team |
Kristina Leigh | Quality Engineer | Team |
Catherine Rogers | Logistics And Customer Service Manager | Team |
Erin Towery | Clinical Research Associate | Team |
Doug Swanson | Principle Area Manager - Limflow | Team |
Complete people profiles for Limflow
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Limflow
4 dated milestones of Limflow across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Limflow is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $40.0M.
- Exit Acquired by Inari Medical.
Competitors of Limflow
Limflow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| csi360.com | 1989 | Saint Paul, United States | $121.34M | 780 | Devices for treating peripheral and coronary vascular disease are developed. | |
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | – | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | |
| angioscore.com | 2003 | Fremont, United States | $87M | – | Scoring balloon catheters for coronary and peripheral angioplasty are developed. | |
| echopointmedical.com | 2018 | London, United Kingdom | $9.74M | 8 | Smart devices for monitoring coronary artery disease are developed. | |
| shapemem.com | 2009 | Santa Clara, United States | $77.27M | 37 | Embolization devices are developed using Shape Memory Polymer foams. | |
| terumo.com | 1921 | Somerset, United States | – | – | Portfolio of medical devices for interventional cardiology is provided. | |
| vasc.com | 1997 | Minneapolis, United States | $12M | 562 | Products for vascular diagnostics and interventional procedures are developed. | |
| ev3.net | 2000 | Plymouth, United States | $58.8M | 1,307 | Surgical products for treatment of Peripheral vascular & Neurovascular diseases | |
| foxhollowtech.com | 1996 | Redwood, United States | $17.72M | – | Medical devices for the treatment of coronary and peripheral arterial disease |
Detailed competitors of Limflow
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Limflow
The website of Limflow (limflow.com) receives about 5K visits a month.
- Monthly visits5K
▲ 37.3% vs previous month
Websites whose visitors overlap most with Limflow. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| radcliffevascular.com | 100% | 4.9K | #3,729,602 | View details | |
vascularnews.com | vascularnews.com | 96% | – | #2,172,450 | – |
techvir.com | techvir.com | 78% | – | #2,986,570 | – |
Latest news on Limflow
Complete news archive for Limflow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Limflow
10 companies that operate in the same segment as Limflow (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Limflow
Limflow was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Limflow is headquartered in Paris, France.
Limflow is a funded company, having raised a total of $97.45M across 4 funding rounds to date.
Developer a system for venous arterialization of the lower limbs. The system employs a minimally invasive, endovascular approach to achieve venous arterialization. Two ultrasound-guided catheters, one venous and one arterial install a crossing nitinol stent, creating an arterio-venous fistula and restoring blood supply to the ischemic foot.
Limflow's top competitors include Contego Medical, Shape Memory Medical and ev3 Endovascular.
Limflow offers LimFlow Procedure.
Limflow has 5 investors. Key investors include Inari Medical, Bpifrance, Longitude Capital, Sofinnova Partners, and Soleus Capital.
Limflow operates through Limflow.
Yes. Limflow was acquired by Inari Medical in November 2023.